Trials / Completed
CompletedNCT00927667
Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
A Diagnostic Interventional, Controlled, Cross-sectional Evaluation of Joint Status Using Magnetic Resonance Imaging in Subjects With Severe Hemophilia A Treated With Primary Prophylaxis, Secondary Prophylaxis, or On-demand Therapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 156 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Male
- Age
- 12 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The joint status (knees, ankles) of patients suffering from severe Hemophilia A (too little blood clotting factor VIII in blood) is evaluated in a single magnetic resonance imaging session. No study medication is given.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | No Drug | Patients have received primary FVIII prophylaxis (started \< 2 years of age) |
| PROCEDURE | No Drug | Patients have received secondary FVIII prophylaxis (started 2 - \< 6 years of age) |
| PROCEDURE | No Drug | Patients have received secondary FVIII prophylaxis (started 6 - \< 12 years of age) |
| PROCEDURE | No Drug | Patients have received secondary VIII prophylaxis(started 12 - 18 years of age) |
| PROCEDURE | No Drug | Patients have received on-demand therapy |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2009-06-25
- Last updated
- 2013-02-20
Locations
15 sites across 6 countries: Germany, Greece, Italy, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00927667. Inclusion in this directory is not an endorsement.